Jury decides in Novozymes’ favor in US patent law suit against Danisco
Jury has found Danisco liable for infringing Novozymes’ US Patent No. 7,713,723 on alpha-amylases for use in the biofuel and starch industries.
A jury in the US District Court for the Western District of Wisconsin found Novozymes’ US Patent No. 7,713,723 valid and ordered Danisco to pay damages of USD 18,290,500 for infringement. The jury also found Danisco’s infringement to be willful.
The jury’s decision is not the final verdict. The decision is subject to the judge’s affirmation and possible appeals, the timing of which is at the courts’ discretion.
Novozymes’ patent covers certain alpha-amylase enzymes for use in the biofuel and starch industries. The infringing products have primarily been used to produce ethanol from corn starch in the US.
Novozymes filed the lawsuit against Danisco in May 2010.
Danisco was acquired by DuPont earlier this year.